These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D, Strife A, Atzpodien J, Clarkson BD. Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231 [Abstract] [Full Text] [Related]
6. The sensitivity to hyperthermia of human granulocyte/macrophage progenitor cells (CFU-GM) derived from blood or marrow of normal subjects and patients with chronic granulocytic leukaemia. Blackburn MJ, Wheldon TE, Field SB, Goldman JM. Br J Cancer; 1984 Dec 15; 50(6):745-51. PubMed ID: 6594154 [Abstract] [Full Text] [Related]
7. Culture of ovine bone marrow-derived macrophages and evidence for serum factors distinct from M-CSF contributing to their propagation in vitro. Francey T, Jungi TW, Rey O, Peterhans E. J Leukoc Biol; 1992 Jun 15; 51(6):525-34. PubMed ID: 1613390 [Abstract] [Full Text] [Related]
9. Characteristics of granulocyte-macrophage colony formation in patients with chronic myelomonocytic leukemia. Katayama T, Miura Y, Suda T, Kusumoto K, Ozawa K, Motoyashi K, Mizoguchi H, Takaku F. Stem Cells (1981); 1982 Jun 15; 1(6):345-54. PubMed ID: 6183760 [Abstract] [Full Text] [Related]
10. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool. Douay L, Lopez M, Gorin NC, Nauman A, Giarratana MC, Laporte JP, Stachowiak J, Salmon C, Duhamel G. Int J Cell Cloning; 1986 Jul 15; 4(4):250-62. PubMed ID: 2875118 [Abstract] [Full Text] [Related]
11. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY. J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433 [Abstract] [Full Text] [Related]
12. Morphologic, immunophenotypic and in vitro growth characteristics of blood and bone marrow associated with stem cell mobilisation in patients with lymphoma. Ghielmini M, Marangoni G, Pampallona S, Tamasy P, Cavalli F. Leuk Lymphoma; 2000 Jul 15; 38(3-4):351-61. PubMed ID: 10830742 [Abstract] [Full Text] [Related]
16. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging. Beran M, Andersson BS, Wang Y, McCredie KB, Farquhar D. Cancer Res; 1988 Jan 15; 48(2):339-45. PubMed ID: 3275495 [Abstract] [Full Text] [Related]
17. Differences in the sensitivity of normal human peripheral blood and bone marrow granulocytic-macrophagic and eosinophilic colony forming cells (CFC) to a source of colony stimulating factor. Chikkappa G, Phillips PG, Brinson P. Exp Hematol; 1982 Nov 15; 10(10):852-8. PubMed ID: 6983975 [Abstract] [Full Text] [Related]
20. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture. Grant S, Bhalla K, Arlin Z, Howe CW. Exp Hematol; 1990 Jan 15; 18(1):41-8. PubMed ID: 2298268 [Abstract] [Full Text] [Related] Page: [Next] [New Search]